Zebinix is an epilepsy medicine used to treat adults with partial-onset seizures (epileptic fits) with or without secondary generalisation. This is a type of epilepsy where too much electrical …

Zebinix可用作单药治疗或添加到现有的抗惊厥疗法中。 推荐的起始剂量为每次400毫克，每天一次，一周或两周后应增加至每次800毫克，每天一次。 根据个体反应，剂量可增加至每次1200毫 …

Eslicarbazepine acetate (ESL), sold under the brand names Aptiom and Zebinix among others, is an anticonvulsant medication approved for use in Europe and the United States as …

2017年5月26日 · 近日，欧洲药品管理局已经批准使用 Bial 和 Eisai 旗下的钠离子通道阻断剂 Zebinix 作为每日一次的单一疗法治疗新诊断为局灶性癫痫的成人患者，扩大了该药物的治疗范 …

What is Zebinix and what is it used for? Zebinix is an epilepsy medicine used to treat adults with partial-onset seizures (epileptic fits) with or without secondary generalisation.

Zebinix may be taken as monotherapy or added to existing anticonvulsant therapy. The recommended starting dose is 400 mg once daily which should be increased to 800 mg once …

Zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation. What is Zebinix and what …

单药治疗新诊断患有癫痫的成人的部分性癫痫发作，伴或不伴继发性全身性发作；辅助治疗成人、青少年和6岁以上儿童的部分性癫痫发作，伴或不伴继发性全身性发作。 北京总部地址：北京 …

Zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Eslicarbazepine acetate (Zebinix®) for the treatment of adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation (November 2010)